SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-028733
Filing Date
2023-05-11
Accepted
2023-05-11 16:15:21
Documents
2
Period of Report
2023-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9239
2 POA DOCUMENT poa.txt EX-24 1701
  Complete submission text file 0001209191-23-028733.txt   12303
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Reporting) CIK: 0001738054 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 23911212